A Study to Compare the Efficacy and Safety of Nebivolol Versus Metoprolol as Dual Therapy with Amlodipine in Patients with Hypertension

Trial Profile

A Study to Compare the Efficacy and Safety of Nebivolol Versus Metoprolol as Dual Therapy with Amlodipine in Patients with Hypertension

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Dec 2015

At a glance

  • Drugs Amlodipine (Primary) ; Metoprolol (Primary) ; Nebivolol (Primary)
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms TANDeM
  • Most Recent Events

    • 11 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top